These emerging treatments , including Semaglutide , belong to a class of drugs called GLP-1 agents. Primarily developed for treating type 2 diabetes , they operate by encouraging the organism to secrete adequate insulin production and limiting excessive sugar levels. Furthermore , their ability to promote slimming has contributed to increased at… Read More